Expression and clinical significance of MUC4 and VEGF in ovarian epithelial tumor

Menon U, Jacobs I. Screening for ovarian cancer [J]. Best Practice and Research:Clinical Obstetrics & Gynaecology, 2002(4):469.

van Nagell JR Jr, DePriest PD, Reedy MB. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer [J]. Gynecologic Oncology, 2000(3):350.doi: 10.1006/gyno.2000.5816.

Auersperg N, Wong AS, Choi KC. Ovarian surface epithelium:biology, endocrinology, and pathology [J]. Endocrine Reviews, 2001(2):255.doi: 10.1210/er.22.2.255.

Karayiannakis AJ, Syrigos KN, Zbar A. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery [J]. Surgery, 2002(5):548.doi: 10.1067/msy.2002.123011.

Garzetti GG, Ciavattini A, Lu carini G. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas:relationship with M1B1 immunostaining [J]. Gynecologic Oncology, 1999.396.doi: 10.1006/gyno.1999.5377.

Hollingsworth MA, Swanson BJ. Mucins in cancer:protection and control of the cell surface [J]. Nature Reviews Cancer, 2004(1):45.

Singh AP, Chaturvedi P, Batra SK. Emerging roles of MUC4 in cancer:a novel target for diagnosis and therapy [J]. Cancer Research, 2007(2):433.doi: 10.1158/0008-5472.CAN-06-3114.

Williams SJ, Wreschner DH, Tran M. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells [J]. Journal of Biological Chemistry, 2001, (21):18327.

Chaturvedi P, Singh AP, Moniaux N. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins [J]. Molecular Cancer Research, 2007(4):309.

Celso A Reis, Hugo Osorio, Luisa Silva, Catarina Gomes, Leonor David. Alterations in glycosylation as biomarkers for cancer detection [J]. Journal of Clinical Pathology, 2010.322.

Chauhan SC, Singh AP, Ruiz F. Aberrant expression of MUC4 in ovarian carcinoma:diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) [J]. Modern Pathology, 2006, (10):1386.

Karavasilis V, Malamou-Mitsi V, Briasoulis E. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage Ⅲ ovarian carcinoma [J]. International Journal of Gynecological Cancer, 2006, (Suppl.1):241.doi: 10.1111/j.1525-1438.2006.00316.x.

Stav Sapoznik, Batya Cohen, Yael Tzuman, Gila Meir, Shifra Ben-Dor, Alon Harmelin. Michal Neeman Gonadotropin-Regulated Lymphangiogenesis in Ovarian Cancer Is Mediated by LEDGF-Induced Expression of VEGF-C [J]. Cancer Research, 2009.9306.

Xiaoyun Liao, Michelle K, Y.Siu, Christy W.H.Au, Esther S.Y.Wong, Hoi Yan Chan, Philip P.C.Ip, Hextan Y.S.Ngan, Annie N.Y.Cheung. Aberrant activation of hedgehog signaling pathway in ovarian cancers:effect on prognosis, cell invasion and differentiation [J]. Carcinogenesis, 2009.131.